Search
argenx SE
ARGXAdd to Watchlist
877.720USD
-14.540-1.63%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
54.32BMarket Cap
36.27P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of argenx SE is 8.62, ranking 93 out of 389 in the Biotechnology & Medical Research industry. The average price target is 925.00, with a high of 1124.00 and a low of 715.00.
Analyst Rating
Based on
26
analysts
Buy
Current Rating
1045.495
Target Price
+19.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
argenx SE
ARGX
26
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is argenx SE's expected revenue for the next quarter?
argenx SE's expected revenue is 1.44B.
What is argenx SE's price target?
Analysts forecast that argenx SE's price target is USD 925.00, with the highest forecast at USD 1.12K and the lowest forecast at USD 715.00.
How have argenx SEARGX's recent earnings per share performed?
The market expectation was USD 5.90, while argenx SEARGX's earnings per share (EPS) for the previous quarter was USD 8.63. EPS for the next quarter is expected at USD 6.14.
What is the analyst rating for argenx SE?
Based on the ratings of argenx SE's stock from 26 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
